Organon & Co. (OGN) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by. My name is Celine and I will be your conference operator today. At this time, I would like to welcome everyone to the Argonauts fourth quarter and full year 2024 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker remarks, there will be a question and answer session. If you would like to ask a question during this time, Simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again. Thank you. I would now like to turn the call over to Jen. Please go ahead. Thank you, Operator. Good morning, everyone. Thank you for joining Organon's fourth quarter and full year 2024 earnings call. With me today are Kevin Ali, Organon's Chief Executive Officer, Matt Walsh, our Chief Financial Officer, and Juan Camilo Arjona-Ferreira, Organon's Head of R&D. Today, we'll be referencing a presentation that will be visible during this call for those of you on our webcast. The presentation will also be available following this call on the Events and Presentations section of our Organon Investor Relations website. Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements. Actual results could differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with the company's business, which are discussed in the company's filings with the Securities and Exchange Commission, including our 10-K and subsequent periodic filings. In addition, we will discuss certain non-GAAP financial measures on this call, which should be considered a supplement to and not a substitute for financial measu...